GENFIT Stock Xetra
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.61 EUR | +21.40% |
|
0.00% | +64.13% |
| Jun. 24 | Oddo BHF Still Positive on Genfit |  |
| Jun. 24 | Genfit's Investigative Treatment for Bile Duct Cancer Shows Positive Results in Phase 1b Study | MT |
| Market Cap | 528M 603M 487M 455M 856M 57.02B 872M 5.84B 2.27B 28.14B 2.27B 2.21B 98.02B | P/E 2025 |
-3.06x | P/E 2026 * | 55.7x |
|---|---|---|---|---|---|
| Enterprise Value | 473M 541M 437M 407M 768M 51.11B 781M 5.24B 2.03B 25.22B 2.03B 1.99B 87.86B | EV / Sales 2025 |
2.34x | EV / Sales 2026 * | 5.05x |
| Free-Float |
86.88% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 month | -4.79% | ||
| 3 months | -6.62% | ||
| 6 months | +71.20% | ||
| Current year | +64.13% |
| 1 month | 8.74 |  | 9.18 |
| Current year | 5.2 | | 9.36 |
| 1 year | 3.19 | | 9.36 |
| 3 years | 3.19 | | 9.36 |
| 5 years | 3.19 | | 9.36 |
| 10 years | 3.19 | | 9.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +21.40% | 0.00% | - | - | 601M | |
| +1.15% | +9.07% | -3.67% | +4.36% | 46.62B | |
| -2.77% | +12.95% | +407.40% | +614.26% | 40.95B | |
| -0.03% | +15.14% | +22.70% | -12.74% | 32.26B | |
| -1.73% | +4.85% | +18.15% | +59.57% | 32.24B | |
| -3.29% | +2.85% | +13.80% | +30.30% | 25.53B | |
| +1.15% | +16.98% | - | - | 16.38B | |
| -0.96% | +16.22% | +70.46% | +125.41% | 15.27B | |
| +0.56% | +8.00% | +12.65% | +21.35% | 13.61B | |
| -1.74% | +4.48% | +99.22% | +92.87% | 13.34B | |
| Average | -0.78% | +10.33% | +80.09% | +116.92% | 26.24B | |
| Weighted average by Cap. | -0.91% | +10.36% | +94.41% | +141.41% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 66.82M 76.33M 61.68M 57.53M 108M 7.22B 110M 740M 287M 3.56B 287M 280M 12.41B | 95.2M 109M 87.88M 81.97M 154M 10.28B 157M 1.05B 409M 5.07B 409M 399M 17.68B |
| Net income | -8.3M -9.49M -7.66M -7.15M -13.47M -897M -13.71M -91.93M -35.69M -443M -35.64M -34.84M -1.54B | 18.31M 20.91M 16.9M 15.76M 29.7M 1.98B 30.23M 203M 78.69M 976M 78.57M 76.82M 3.4B |
| Net Debt | -54.72M -62.52M -50.51M -47.12M -88.78M -5.91B -90.37M -606M -235M -2.92B -235M -230M -10.16B | -46.87M -53.54M -43.26M -40.36M -76.04M -5.06B -77.4M -519M -201M -2.5B -201M -197M -8.7B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
